zhanusova 02.08.2017

Přehled publikací členů laboratoře

Prionová laboratoř je zaměřena především na základní výzkum prionů a prionových chorob, dalších proteinopatií a buněčné toxicity nanočástic.

2017

Hanusova Z, Mosko T, Marej R, Holada K. Precision in the design of an experimental study deflects the significance of proteinase-activated receptor 2 expression in scrapie-inoculated mice. J Gen Virol. 2017;98(6):1563–1569. [pubmed]

Safarik M, Mosko T, Zawada Z, Safarikova E, Dracinsky M, Holada K, Sebestik J. Reactivity of 9-aminoacridine drug quinacrine with glutathione limits its antiprion activity. Chem Biol Drug Des. 2017;89(6):932–942. [pubmed]

2016

Filipova M, Rusina R, Holada K. Nanočástice jako nosiče léků přes hematoencefalickou bariéru – naděje pro léčbu neurodegenerativních onemocnění v budoucnosti? Cesk Slov Neurol N. 2016;79(2):160–167. [abstrakt]

2015

Jindrova Z, Hanusova Z, Holada K. Proteasami aktivované receptory: aktivace, inhibice a farmaceutický význam. Chemicke listy. 2015;109(7):507–514. [abstrakt]

Hanusova Z, Kucerova J, Filipova M, Jindrova Z, Holada K.Prionový protein, jeho úloha v buněčné proliferaci, diferenciaci a vývoji nervové soustavy. Cesk Slov Neurol N. 2015;78(4):406–412. [abstrakt]

Glier H, Simak J, Panigaj M, Gelderman MP, Vostal JG, Holada K. Expression of the cellular prion protein affects posttransfusion recovery and survival of red blood cells in mice. Transfusion. 2015;55(11):2590–2596. [pubmed]

Matej R, Rohan Z, Holada K, Olejar T. The Contribution of Proteinase-Activated Receptors to Intracellular Signaling, Transcellular Transport and Autophagy in Alzheimer´s Disease. Curr Alzheimer Res. 2015;12(1):2–12. [pubmed]

2014

Orecna M, De Paoli SH, Janouskova O, Tegegn TZ, Filipova M, Bonevich JE, Holada K, Simak J. Toxicity of carboxylated carbon nanotubes in endothelial cells is attenuated by stimulation of the autophagic flux with the release of nanomaterial in autophagic vesicles. Nanomedicine. 2014; 10(5):939–948. [pubmed]

De Paoli SH, Diduch LL, Tegegn TZ, Orecna M, Strader MB, Karnaukhova E, Bonevich JE, Holada K, Simak J. The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets. Biomaterials. 2014; 35(24):6182–6194. [pubmed]

2013

Dvorakova E, Vranac T, Janouskova O, Cernilec M, Koren S, Lukan A, Novakova J, Matej R, Holada K, Curin Serbec V. Detection of the GPI-anchorless prion protein fragment PrP226* in human brain. BMC Neurol. 2013;13:126. [pubmed]

Zawada Z, Safarik M, Dvorakova E, Janouskova O, Brezinova A, Stibor I, Holada K, Bour P, Hlavacek J, Sebestik J. Quinacrine reactivity with prion proteins and prion-derived peptides. Amino Acids. 2013;44(5):1279–1292. [pubmed]

Rusina R, Fiala J, Holada K, Matejckova M, Novakova J, Ampapa R, Koukolik F, Matej R. Gerstmann-Sträussler-Scheinker syndrome with the P102L pathogenic mutation presenting as familial Creutzfeldt-Jakob disease: a case report and review of the literature. Neurocase. 2013;19(1):41–53. [pubmed]

2012

Janouskova O, Rakusan J, Karaskova M, Holada K. Photodynamic inactivation of prions by disulfonated hydroxyaluminium phthalocyanine. J Gen Virol. 2012;93:2512–2517. [pubmed]

Matej R, Olejar T, Janouskova O, Holada K. Deletion of protease-activated receptor 2 prolongs survival of scrapie-inoculated mice. J Gen Virol. 2012;93:2057–2061. [pubmed]

Glier H, Holada K. Blood storage affects the detection of cellular prion protein on peripheral blood leukocytes and circulating dendritic cells in part by promoting platelet satellitism. J Immunol Methods. 2012;380:65–72. [pubmed]

Julak J, Scholtz V, Kotucova S, Janouskova O. The persistent microbicidal effect in water exposed to the corona discharge. Phys Med. 2012 Jul;28(3):230–239. [pubmed]

Dvorakova E, Holada K. Konformačně specifické protilátky a diagnostika prionových chorob. Cesk Slov Neurol N. 2012;75(3):283–290. [abstrakt]

2011

Dvorakova E, Prouza M, Janouskova O, Panigaj M, Holada K. Development of monoclonal antibodies specific for glycated prion protein. J Toxicol Environ Health A. 2011;74:1469–1475. [pubmed]

Panigaj M, Glier H, Wildova M, Holada K. Expression of prion protein in mouse erythroid progenitors and differentiating murine erythroleukemia cells. PLoS One. 2011;6(9):e24599. [pubmed]

De Paoli Lacerda SH, Semberova J, Holada K, Simakova O, Hudson SD, Simak J. Carbon Nanotubes Activate Store-Operated Calcium Entry in Human Blood Platelets. ACS Nano 2011;5:5808–5813. [pubmed]

Panigaj M, Brouckova A, Glierova H, Dvorakova E, Simak J, Vostal JG, Holada K. Underestimation of the expression of cellular prion protein on human red blood cells. Transfusion. 2011;51(5):1012–1021. [pubmed]

Julak J, Janouskova O, Scholtz V, Holada K. Inactivation of prions using electrical DC discharges at atmospheric pressure and ambient temperature. Plasma Process Polym. 2011; 8(4): 316–323. [abstrakt]

2010

Hobzova K, Janouskova O. Tkáňové kultury pro studium prionových chorob. Cesk Slov Neurol N. 2010;73(4):379–386. [abstrakt]

2009

Brouckova A, Holada K. Cellular prion protein in blood platelets associates with both lipid rafts and the cytoskeleton. Thromb Haemost. 2009;102(5): 966–974. [pubmed]

Semberova J, De Paoli Lacerda SH, Simakova O, Holada K, Gelderman MP, Simak J. Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. Nano Lett. 2009 Sep;9(9):3312–3317. [pubmed]

2008

Zivny JH, Gelderman MP, Xu F, Piper J, Holada K, Simak J, Vostal JG. Reduced erythroid cell and erythropoietin production in response to acute anemia in prion protein-deficient (Prnp-/-) mice. Blood Cells Mol Dis. 2008 May-Jun;40(3):302–307. [pubmed]

2007

Holada K, Simak J, Brown P, Vostal JG. Divergent expression of cellular prion protein on blood cells of human and nonhuman primates. Transfusion. 2007 Dec;47(12):2223–2232. [pubmed]

Pavlicek A, Bednarova L, Holada K. Production, purification and oxidative folding of the mouse recombinant prion protein. Folia Microbiol. 2007;52(4):391–397. [pubmed]

2006

Holada K, Glierova H, Simak J, Vostal JG. Expression of cellular prion protein on platelets from patients with gray platelet or Hermansky-Pudlak syndrome and the protein’s association with alpha-granules. Haematologica. 2006 Aug;91(8):1126–1129. [pubmed]
počet zobrazení: 25 poslední aktualizace: zhanusova, 02.08.2017
Hodnocení: Kliknutím na tento odkaz upozorníte autora, že jeho článek už zřejmě není aktuální.

Kalendář

UIM Webcalendar

uim-webcalendar.lf1.cuni.cz